Download PDF
Thromb Haemost 1974; 32(01): 157-170
DOI: 10.1055/s-0038-1647682
Original Article
Schattauer GmbH

Effects of Alpha and Beta Receptor Stimulating and Blocking Agents on Experimental Disseminated Intravascular Coagulation

M Moriau
1   Laboratory for Haemostasis and Thrombosis Research, University of Louvain, Louvain, Belgium
,
H Noel   *
1   Laboratory for Haemostasis and Thrombosis Research, University of Louvain, Louvain, Belgium
,
R Masure
1   Laboratory for Haemostasis and Thrombosis Research, University of Louvain, Louvain, Belgium
› Author Affiliations
Further Information

Publication History

Received 20 December 1973

Accepted after resubmission 18 April 1974

Publication Date:
30 June 2018 (online)

    Permissions and Reprints

Summary

In this experimental study on rabbits, we compare the haemostatic and histological changes observed in animals with disseminated intravascular coagulation (DIC) induced by thrombin perfusion (100 u/kg/hr during 3 hours) with or without preventive administration of alpha and beta receptor stimulating or blocking agents.

Both alpha and beta receptor stimulating agents enhance the disorders induced by thrombin alone, while alpha or beta blocking agents reduce them.

This favourable action is still more pronounced with the combination of these two last types of drugs.

The modifications observed appear to be related to changes in platelet function.

* Laboratory of Pathology.


 

  • References

  • 1 Berk J. L, Hagen J. F, Beyer W. H, Dochat G. R, Lapointe R. 1967; The treatment of haemorrhagic shock by beta adrenergic receptor blockade. Surgery, Gynecology and Obstetrics 125: 1.
    PubMedGoogle Scholar
  • 2 Berk J. L, Hagen J. F, Beyer W. H, Gerberg M. J, Dochat G. R. 1969; The treatment of endotoxin shock by beta adrenergic blockade. Annals of Surgery 169: 74.
    CrossrefPubMedGoogle Scholar
  • 3 Born G. V. R, Cross M. J. 1963; The aggregation of blood platelets. Journal of Physiology 168: 178.
    CrossrefPubMedGoogle Scholar
  • 4 Born G. V. R, Mills D. C. B, Roberts G. C. K. 1967; Potentiation of platelet aggregation by adrenaline. Proceedings of the Physiological Society 191: 43.
    PubMedGoogle Scholar
  • 5 Bucher H. W, Stucki P. 1969; The effect of various beta receptor blocking agents on platelet aggregation. Experientia 25: 280.
    CrossrefPubMedGoogle Scholar
  • 6 Bygdeman S, Johnsen O. 1969; Studies on the effect of adrenergic blocking drugs on catecholamine induced platelet aggregation and uptake of noradrenaline and 5 hydroxytryptamine. Acta physiologica Scandinavica 75: 129.
    CrossrefPubMedGoogle Scholar
  • 7 Caen J. 1961; Le temps de Stypven. Pathologie et Biologie 09: 180.
    PubMedGoogle Scholar
  • 8 Cohen R. J, Epstein S. E, Cohen L. S, Dennis L. H. 1968; Alteration of fibrinolysis and blood coagulation induced by exercise and the role of beta adrenergic receptor stimulation. Lancet 02: 1264.
    PubMedGoogle Scholar
  • 9 Halmagyi D. F. J, Starczecki B, Horner G. J. 1963; Mechanism and pharmacology of endotoxin shock in sheep. Journal of Applied Physiology 18: 544.
    CrossrefPubMedGoogle Scholar
  • 10 Hampton J. R, Harrisson H. J. G, Honour A. J, Mitchell J. R. A. 1967; Platelet behaviour and drugs used in cardiovascular diseases. Cardiovascular Research 02: 101.
    PubMedGoogle Scholar
  • 11 Hellem A. J. 1970; Platelet adhesiveness in von Willebrand’s disease. Scandinavian Journal of Haematology 07: 374.
    PubMedGoogle Scholar
  • 12 Ingram G. I. C. 1961; Increase in antihaemophilic globulin activity following infusion of adrenaline. Journal of Physiology 156: 217.
    CrossrefPubMedGoogle Scholar
  • 13 Janssen C. L, Masure R. 1970; Enzymatic method for the quantitative determination of factor XIII. Application to a familial deficiency. Pathologia europaea 05: 315.
    PubMedGoogle Scholar
  • 14 Joist J. H, Pechan J, Gross R. 1970. The effect of beta receptor blocking agents on platelet function in vitro and in vivo. In: Platelets and the vessel wall fibrin deposition. Gotthard Schettler. Georg Thieme Verlag; Stuttgart: 59.
    Google Scholar
  • 15 Kardos G. G. 1966; Isoproterenol in the treatment of shock due to bacteremia with gram negative pathogens. New England Journal of Medicine 274: 868.
    CrossrefPubMedGoogle Scholar
  • 16 Kubisz P, Levy Toledano S, Cronberg S, Pinkhas J, Caen J. 1970; Effect of phentolamine, an alpha receptor blocking agent on epinephrine, ADP and collagen induced platelet factor 4 release and platelet aggregation. Revue européenne d’études cliniques et biologiques 15: 429.
    PubMedGoogle Scholar
  • 17 Kubisz P, Suranova J. 1972; The effect of alpha and beta receptor blocking agents on collagen induced platelet release reaction. Thrombosis et Diathesis Haemorrhagica 27: 278.
    PubMedGoogle Scholar
  • 18 Kubisz P, Caen J. 1972; Interaction of alpha and beta receptor blocking agents with platelet release and availability reaction induced by ADP, adrenaline and collagen. Pathologie et Biologie 20: 34.
    PubMedGoogle Scholar
  • 19 Lillehei R. C, Longerbeam J. K, Block J. H, Massax W. G. 1964; The modern treatment of shock based on physiologic principles. Clinical Pharmacology and Therapeutics 05: 63.
    PubMedGoogle Scholar
  • 20 McClure P. D, Ingram G. I. C, Jones V. G. 1965; Platelet changes after adrenalin infusions with and without adrenaline blockers. Thrombosis et Diathesis Haemorrhagica 13: 136.
    PubMedGoogle Scholar
  • 21 McKay D. G. 1969; Tissue damage in disseminated intravascular coagulation, mechanism of localization of thrombi in the microcirculation. Thrombosis et Diathesis Haemorrhagica suppl. 36: 67.
    PubMedGoogle Scholar
  • 22 McKay D. G, Latour J. G, Parrish M. H. 1970; Activation of Hageman factor by alpha adrenergic stimulation. Thrombosis et Diathesis Haemorrhagica 23: 417.
    PubMedGoogle Scholar
  • 23 McKay D. G, Latour J. G, Lopez A. M. 1971; Production of generalized Shwartzman reaction by activated Hageman factor and alpha adrenergic stimulation. Thrombosis et Diathesis Haemorrhagica 27: 71.
    PubMedGoogle Scholar
  • 24 McLean L. D, Duff J. H, Scott H. M, Peretz D. I. 1965; Treatment of shock in man based on haemodynamic diagnosis. Surgery, Gynecology and Obstetrics 120: 1.
    PubMedGoogle Scholar
  • 25 Mills D. C. B, Roberts G. C. K. 1967; Effect of adrenaline on human blood platelets. Journal of Physiology 193: 443.
    CrossrefPubMedGoogle Scholar
  • 26 Moriatt M. 1969; Inhibiteurs naturels de la fibrinolyse et phénomènes thrombohémorra- giques. Pathologia europaea, 4, suppl 01: 1.
    PubMedGoogle Scholar
  • 27 Müller Berghaus G, Davidson E, McKay D. G. 1967; Prevention of the generalized Shwartzman reaction in pregnant rats by alpha adrenergic blockade. Effect on the coagulation mechanism. Obstetrics and Gynecology 30: 11.
    PubMedGoogle Scholar
  • 28 Müller Berghaus G. 1969; Pathophysiology of disseminated intravascular coagulation. Thrombosis et Diathesis Haemorrhagica, suppl 36: 45.
    PubMedGoogle Scholar
  • 29 Nickerson M. 1962. Drug therapy of shock. In: Shock, Pathogenesis and Therapy. K. Bock; Springer. Berlin: 356.
    Google Scholar
  • 30 O’Brien 1963; Some effects of adrenaline and antiadrenaline compounds on platelets in vitro and in vivo. Nature 200: 763.
    CrossrefPubMedGoogle Scholar
  • 31 Palmiero C, Ming S. C, Frantz E, Fine J. 1962; The role of the sympathetic nervous system in the generalized Shwartzman reaction. Journal of Experimental Medicine 115: 609.
    CrossrefPubMedGoogle Scholar
  • 32 Ponari O, Cvardi E, Megha A, Pini M, Poti R, Dettori A. G. 1973; Effect of alpha and beta blocking drugs on the clotting and fibrinolytic respons to venous stasis in man. British Journal of Haematology 24: 463.
    CrossrefPubMedGoogle Scholar
  • 33 Rysanek K, Svehla C, Spankova M, Mlejnkova M. 1968; Comparison on the effect of various sympathicolytics on thrombocytes aggregation. Journal of Pharmacy and Pharmacology 20: 154.
    CrossrefPubMedGoogle Scholar
  • 34 Sacchetti G, Bellani D, Montanari C, Gibelli A. 1973; Effects in vitro of some cardiovascular drugs and other agents on human platelet aggregation. Thrombosis et Diathesis Haemorrhagica 29: 190.
    PubMedGoogle Scholar
  • 35 Starzecki B, Reddin J. L, Spink W. W. 1968; Effect of isoproterenol on survival in canine endotoxin shock. Annals of Surgery 167: 35.
    CrossrefPubMedGoogle Scholar
  • 36 Thomas D. P. 1967; Effect of catecholamines on platelet aggregation caused by thrombin. Nature 215: 198.
    PubMedGoogle Scholar
  • 37 Vick J. A, Cinchta H. P, Mantheri J. H. 1965; Use of isoproterenol and phenoxybenzamine in treatment of endotoxin shock. Journal of Pharmacology and Experimental therapeutics 150: 382.
    PubMedGoogle Scholar
  • 38 Weiss H. J. 1972. The pharmacology of platelet inhibition. In: Spaet T. h.H. (ed.) Progress in Hemostasis and Thrombosis. vol. 1. Grune and Stratton; New York and London: 199.
    Google Scholar
  • 39 Whitaker A. N, McKay D. G, Csavossy I. 1969; Studies of cathecolamine shock. American Journal of Pathology 56: 153.
    PubMedGoogle Scholar
  • 40 Yamazaki M, Sano T, Odakura T, Takencki K, Metsumura T, Hosaki S, Shimamoto T. 1971; Appearance of thrombogenic tendency induced by adrenaline and its prevention by beta adrenergic blocking agents, nialamide and pyridinolcarbamate. Thrombosis et Diathesis Haemorrhagica 26: 251.
    PubMedGoogle Scholar
  • 41 Yamazaki H, Kobayashi I, Sano T, Shimamoto T. 1973; Enhancement of ADP induced platelet aggregation by adrenaline in vivo and its prevention. Thrombosis et Diathesis Haemorrhagica 29: 490.
    PubMedGoogle Scholar